Published in Drug Des Devel Ther on September 02, 2014
Adverse drug reaction and causality assessment scales. Lung India (2011) 1.86
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. Drug Saf (2013) 1.22
Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia. J Thromb Haemost (2006) 1.08
Allopurinol hypersensitivity reactions: desensitization strategies and new therapeutic alternative molecules. Inflamm Allergy Drug Targets (2013) 0.90
Skin testing and patch testing in non-IgE-mediated drug allergy. Curr Allergy Asthma Rep (2014) 0.90
Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy. Acta Paediatr Jpn (1993) 0.84
Lenalidomide-induced purpuric eruption: a new adverse cutaneous reaction. J Am Acad Dermatol (2011) 0.83
Hypofibrinogenemia induced by prednisolone therapy in a patient with chronic lymphocytic leukemia complicated with autoimmune hemolytic anemia. Am J Hematol (1997) 0.83
Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke. Thromb Res (2012) 0.83
Hypofibrinogenemia associated with vincristine and prednisone therapy in lymphoblastic leukemia. Cancer (1975) 0.80
Frictional purpuric eruption associated with angiotensin II receptor blockers. Dermatol Ther (2013) 0.80
Purpuric drug eruption with leukocytoclastic vasculitis due to gefitinib. J Dermatol (2010) 0.80
Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review. Drug Des Devel Ther (2013) 0.79